Literature DB >> 28625358

Disruption of xanthine oxidoreductase gene attenuates renal ischemia reperfusion injury in mice.

Yoshie Haga1, Toshio Ohtsubo2, Noboru Murakami1, Hideko Noguchi1, Yasuo Kansui3, Kenichi Goto1, Kiyoshi Matsumura1, Takanari Kitazono1.   

Abstract

AIMS: We examined the roles of xanthine oxidoreductase (XOR) in renal ischemia reperfusion (IR) injury. MAIN
METHODS: XOR+/+ and XOR+/- mice were subjected to 24-h reperfusion after a 45-min bilateral renal artery occlusion or sham operation. We evaluated the renal damage based on the concentrations of blood urea nitrogen (BUN) and serum creatinine (Cr), and histological changes were detected by PAS staining. Xanthine dehydrogenase, oxidase (XO) and XOR activities, amounts of blood and urine 8-OHdG, and expressions of TNF-α and MCP-1 mRNA were examined. F4/80 and nitrotyrosine-positive cells were assessed by immunohistochemical staining. KEY
FINDINGS: The BUN and Cr concentrations in the XOR+/+IR mice were increased significantly compared to those in XOR+/-IR and allopurinol-treated XOR+/+IR mice. XO and XOR activity, which were increased in IR mice, were reduced in the allopurinol-treated XOR+/+IR and XOR+/-IR mice compared to the XOR+/+IR mice. The concentrations of blood and urine 8-OHdG, and the expressions of MCP-1 and TNF-α mRNA were increased significantly in the XOR+/+IR mice compared to those in the XOR+/-IR mice. The histological analysis revealed that the XOR+/-IR and allopurinol-treated XOR+/+IR mice showed less tubular injury than the XOR+/+IR mice in the cortex regions, with the reduction of inflammation and oxidative stress assessed by the immunohistological staining for F4/80 and nitrotyrosine. SIGNIFICANCE: Both the disruption of XOR gene in XOR+/- mice and the reduction of XOR activity in allopurinol-treated XOR+/+IR mice attenuated renal tissue injury in this IR model. Reduced XOR activity during renal IR could be a beneficial treatment target.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Inflammation; Ischemia reperfusion; Mouse; Reactive oxygen species; Renal injury; Xanthine oxidoreductase

Mesh:

Substances:

Year:  2017        PMID: 28625358     DOI: 10.1016/j.lfs.2017.06.011

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  3 in total

1.  Xanthine oxidase inhibitor ameliorates postischemic renal injury in mice by promoting resynthesis of adenine nucleotides.

Authors:  Kentaro Fujii; Akiko Kubo; Kazutoshi Miyashita; Masaaki Sato; Aika Hagiwara; Hiroyuki Inoue; Masaki Ryuzaki; Masanori Tamaki; Takako Hishiki; Noriyo Hayakawa; Yasuaki Kabe; Hiroshi Itoh; Makoto Suematsu
Journal:  JCI Insight       Date:  2019-11-14

2.  Safety and Efficacy of Benzbromarone and Febuxostat in Hyperuricemia Patients with Chronic Kidney Disease: A Prospective Pilot Study.

Authors:  Haibo Yu; Xinying Liu; Yaxiang Song; Jiafen Cheng; Hui Bao; Ling Qin; Xuan Zhou; Ling Wang; Ai Peng
Journal:  Clin Exp Nephrol       Date:  2018-05-14       Impact factor: 2.801

3.  Systematic analysis of the expression profile of non-coding RNAs involved in ischemia/reperfusion-induced acute kidney injury in mice using RNA sequencing.

Authors:  Jun Zhou; Hongtao Chen; Youling Fan
Journal:  Oncotarget       Date:  2017-10-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.